Literature DB >> 13303018

Reserpine-hydralazine combination therapy of hypertensive disease, with hydralazine in doses generally below the toxic range.

R E LEE, A M SELIGMANN, D GOEBEL, L A FULTON, M A CLARK.   

Abstract

Entities:  

Keywords:  HYPERTENSION/therapy; RAUWOLFIA ALKALOIDS/therapeutic use; SYMPATHOLYTICS/therapeutic use

Mesh：

Substances：

Year:  1956        PMID： 13303018     DOI： 10.7326/0003-4819-44-3-456

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  3 in total

Review 1.  Blood pressure-lowering efficacy of reserpine for primary hypertension.

Authors:  Sandy D Shamon; Marco I Perez
Journal:  Cochrane Database Syst Rev       Date:  2016-12-21

Review 2.  Combination pharmacotherapy in hypertension.

Authors:  George S Stergiou
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

Review 3.  Combination drug treatment of hypertension: have we come full circle?

Authors:  Addison A Taylor
Journal:  Curr Cardiol Rep       Date:  2004-11       Impact factor: 2.931
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.